Vistogard

Active Ingredient(s): Uridine Triacetate
FDA Approved: * December 11, 2015
Pharm Company: * WELLSTAT THERAP
Category: Genetic Disorders

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Vistogard Overview

Uridine is a glycosylated pyrimidine-analog containing uracil attached to a ribose ring (or more specifically, a ribofuranose) via a β-N1-glycosidic bond. It is one of the five standard nucleosides which make up nucleic acids, the others being adenosine, thymidine, cytidine and guanosine. The five nucleosides are commonly abbreviated to their one-letter codes U, A, T, C and G respectively. However, thymidine is more commonly written as 'dT' ('d' represents 'deoxy') as it contains a 2'-de...

Read more Vistogard Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Uridine

Recent Vistogard Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Vistogard: (1 result)

Sorted by National Drug Code

• 69468-151 Vistogard 951 mg/g Oral Granule by Wellstat Therapeutics Corporation

Other drugs which contain Uridine Triacetate or a similar ingredient: (2 results)

• URIDINE TRIACETATE
• XURIDEN Uridine Triacetate